2.3.1.41	beta-ketoacyl-[acyl-carrier-protein] synthase i deficiency	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25893869&form=6&db=m	OsKASI, a ?-ketoacyl-[acyl carrier protein] synthase I, is involved in root development in rice (Oryza sativa L.).	unassigned	-	
2.3.1.41	Breast Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11935210&form=6&db=m	Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells.	causal interaction,ongoing research,therapeutic application,unassigned	4,4,4,0	
2.3.1.41	Myocardial Infarction	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=13753350&form=6&db=m	Condensing enzyme levels in the serum after experimental myocardial infarction.	diagnostic usage,unassigned	4,0	
2.3.1.41	Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15715465&form=6&db=m	Application of a flexible synthesis of (5R)-thiolactomycin to develop new inhibitors of type I fatty acid synthase.	ongoing research,therapeutic application,unassigned	4,1,0	
2.3.1.41	Tuberculosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9616124&form=6&db=m	Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid.	ongoing research,therapeutic application,unassigned	2,3,0	
2.3.1.41	Tuberculosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11600501&form=6&db=m	Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB.	ongoing research,unassigned	4,0	
2.3.1.41	Tuberculosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12023885&form=6&db=m	Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis.	ongoing research,unassigned	4,0	
2.3.1.41	Tuberculosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14552758&form=6&db=m	Biphenyl-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme.	ongoing research,therapeutic application,unassigned	1,2,0	
2.3.1.41	Tuberculosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14698162&form=6&db=m	Acetylene-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme.	ongoing research,therapeutic application,unassigned	1,2,0	
2.3.1.41	Tuberculosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17174327&form=6&db=m	X-ray crystal structure of Mycobacterium tuberculosis beta-ketoacyl acyl carrier protein synthase II (mtKasB).	causal interaction,ongoing research,therapeutic application,unassigned	3,2,4,0	
2.3.1.41	Tuberculosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18703500&form=6&db=m	A novel interaction linking the FAS-II and phthiocerol dimycocerosate (PDIM) biosynthetic pathways.	therapeutic application,unassigned	1,0	
2.3.1.41	Tuberculosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19440303&form=6&db=m	Identification of 2-Aminothiazole-4-Carboxylate Derivatives Active against Mycobacterium tuberculosis H(37)R(v) and the beta-Ketoacyl-ACP Synthase mtFabH.	ongoing research,therapeutic application,unassigned	1,2,0	
2.3.1.41	Tuberculosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24108128&form=6&db=m	Structural basis for the recognition of mycolic acid precursors by KasA, a condensing enzyme and drug target from Mycobacterium tuberculosis.	ongoing research,therapeutic application,unassigned	1,1,0	
2.3.1.41	Tuberculosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28856604&form=6&db=m	In Silico Drug Design of Thiolactomycin Derivatives Against Mtb-KasA Enzyme to Inhibit Multidrug Resistance of Mycobacterium tuberculosis.	unassigned	-